aid: rakuten-medical
name: Rakuten Medical
image: https://rakuten-med.com/us/wp-content/uploads/sites/6/2021/02/RakutenMedical_KV.png
description: 'Rakuten Medical, Inc. is a global biotechnology company headquartered in San Diego, California,
  developing precision, cell-targeting investigational cancer therapies on its proprietary Alluminox
  platform — a drug-device combination pairing an IRDye 700DX light-activated dye conjugated to a
  cell-targeting antibody with local illumination by 690nm red light. Founded in 2010 as Aspyrian
  Therapeutics and renamed following investment from Rakuten Group, the company operates in the United
  States, Japan, Taiwan, Switzerland and India. Its lead asset ASP-1929, an EGFR-targeting antibody-dye
  conjugate, received marketing approval in Japan in 2021 as Akalux for unresectable locally advanced
  or recurrent head and neck cancer and is in global Phase 3 development alone and in combination with
  anti-PD-1 therapy; RM-1995 and RM-0256 follow in earlier-stage programs. As a clinical-stage
  therapeutics and drug-device company, Rakuten Medical publishes no public developer API, SDK, webhook,
  or machine-readable specification; this profile captures its corporate identity and public web
  properties in the API Evangelist network.'
url: https://raw.githubusercontent.com/api-evangelist/rakuten-medical/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Healthcare
- Life Sciences
- Photoimmunotherapy
- Medical Devices
- Clinical Trials
- Cancer
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/rakuten-medical-domain-security.yml
- type: LLMsTxt
  url: llms/rakuten-medical-llms.txt
- type: Website
  url: https://rakuten-med.com/us/
- type: About
  url: https://rakuten-med.com/us/about/
- type: Blog
  url: https://rakuten-med.com/us/news/
- type: BlogRSS
  url: https://rakuten-med.com/us/feed/
- type: News
  url: https://rakuten-med.com/us/news/press-releases/
- type: Support
  url: https://rakuten-med.com/us/contact/
- type: Careers
  url: https://rakuten-med.com/us/recruitment/
- type: PrivacyPolicy
  url: https://rakuten-med.com/us/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/rakuten-medical/
- type: Profile
  url: https://forgeglobal.com/rakuten-medical_stock/
x-enrichment:
  date: '2026-08-05'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Rakuten Medical is a clinical-stage biotechnology company whose product is a drug-device cancer
    therapy (an IRDye 700DX antibody conjugate plus a 690nm laser), sold to hospitals and regulated
    by PMDA and FDA rather than integrated by developers; its only web property is a WordPress
    corporate site, and the sole non-www host that resolves, portal.rakuten-med.com, is an F5 BIG-IP
    employee VPN that answers 200 with the same HTML logout page for every path.
  evidence:
  - url: https://rakuten-med.com/us/openapi.json
    status: 404
  - url: https://rakuten-med.com/us/.well-known/api-catalog
    status: 404
  - url: https://rakuten-med.com/us/.well-known/agent-card.json
    status: 404
  - url: https://rakuten-med.com/us/llms.txt
    status: 404
  - url: https://rakuten-med.com/us/developers
    status: 404
  - url: https://portal.rakuten-med.com/.well-known/agent-card.json
    status: 200
  - url: https://rakuten-med.com/us/pipeline/
    status: 200
  checked: '2026-08-05'